Salvage Therapy

For some patients, initial induction therapy does not achieve remission. These patients are said to have primary resistant or refractory disease. Of those that do achieve remission with induction therapy, some will suffer a relapse within the 2 to 3 years following induction therapy. These patients are said to have relapsed disease. For both of these groups of patients, salvage therapy is required with the aim of inducing a first or second remission.

For patients with relapsed disease, treatment may involve a similar regimen to their first induction therapy. For many patients, particularly those who did not achieve a first remission, it will involve a different regimen made up of different chemotherapy and medication types known as salvage therapy or rescue therapy. A number of new anti-leukaemia medications have been developed for this purpose. Some patients who need salvage therapy enrol in a clinical trial designed for treatment of resistant or relapsed disease. 



Co to jest leczenie ratunkowe?

Dr Agnieszka Wierzbowska z Uniwersytetu Medycznego w Lodzi tlumaczy, na czym polega leczenie ratunkowe.


La terapia di salvataggio

La dott.ssa Chiara Bonini, docente all’Università Vita-Salute San Raffaele di Milano (IT), al Congresso Annuale dell’ASH (American Society of Hematology) spiega che, durante il percorso di induzione e consolidamento, nel quale l’obiettivo è di mantenere la malattia in remissione completa, può succedere di dover mettere in atto un nuovo trattamento a causa di una recidiva.


Terapia de salvamento em leucemias agudas

Neste vídeo educativo, o Dr. Eduardo Rego da Universidade de São Paulo, São Paulo, Brasil, descreve a terapia de salvamento.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on April 3, 2017